Mostrar registro simples

dc.contributor.authorFreeman, Tobypt_BR
dc.contributor.authorGiugliani, Camilapt_BR
dc.contributor.authorVillar, Eugeniopt_BR
dc.date.accessioned2023-10-03T03:36:09Zpt_BR
dc.date.issued2023pt_BR
dc.identifier.issn0168-8510pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/265628pt_BR
dc.description.abstractPrevious research on commercial determinants of health has primarily focused on their impact on non-communicable diseases. However, they also impact on infectious diseases and on the broader preconditions for health. We describe, through case studies in 16 countries, how commercial determinants of health were visible during the COVID-19 pandemic, and how they may have influenced national responses and health outcomes. We use a comparative qualitative case study design in selected low- middle- and high-income countries that performed differently in COVID-19 health outcomes, and for which we had country experts to lead local analysis. We created a data collection framework and developed detailed case studies, including extensive grey and peer-reviewed literature. Themes were identified and explored using iterative rapid literature reviews. We found evidence of the influence of commercial determinants of health in the spread of COVID-19. This occurred through working conditions that exacerbated spread, including precarious, low-paid employment, use of migrant workers, procurement practices that limited the availability of protective goods and services such as personal protective equipment, and commercial actors lobbying against public health measures. Commercial determinants also influenced health outcomes by influencing vaccine availability and the health system response to COVID-19. Our findings contribute to determining the appropriate role of governments in governing for health, wellbeing, and equity, and regulating and addressing negative commercial determinants of health.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofHealth policy. Amsterdam. Vol. 134 (2023), 104860, 11 f.pt_BR
dc.rightsOpen Accessen
dc.subjectComparative studyen
dc.subjectCOVID-19pt_BR
dc.subjectHealth equityen
dc.subjectEstudo comparativopt_BR
dc.subjectEquidade em saúdept_BR
dc.subjectPrivatisationen
dc.subjectPrivatizaçãopt_BR
dc.subjectSocial determinants of healthen
dc.subjectDeterminantes sociais da saúdept_BR
dc.titleIllustrating the impact of commercial determinants of health on the global COVID-19 pandemic : thematic analysis of 16 country case studiespt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001173221pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples